In this cohort, 20 of 41 (48.7%) TMA ccRCC specimens were ZMYND8-positive, but none of the normal kidney specimens expressed high levels of ZMYND8 (Fig. 2H). Here, ZMYND8 is linked to nonpapillary renal cell carcinoma.